BCHT Biotechnology

Explore the latest insights on BCHT Biotechnology and its impact on China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of BCHT Biotechnology’s developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.Explore the latest insights on BCHT Biotechnology and its impact on China's pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of BCHT Biotechnology's developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

RonGu Biotechnology Completes Series A Financing of Nearly RMB 100 Million – Advancing Off‑the‑Shelf CAR‑NK and CAR‑T Therapies for Systemic Lupus Erythematosus
CompanyDeals

RonGu Biotechnology Completes Series A Financing of Nearly RMB 100 Million – Advancing Off‑the‑Shelf CAR‑NK and CAR‑T Therapies for Systemic Lupus Erythematosus

Hangzhou RonGu Biotechnology Co., Ltd. ("RonGu Biotechnology") announced the completion of a Series A financing of nearly RMB 100 million. The round was jointly participated by Changjin Holdings, Yichen Investment,…

Eisai and Siemens Healthineers Sign Strategic Cooperation Agreement at CIIE – Advancing Precision Imaging in Alzheimer's Disease Diagnosis and Treatment

Eisai and Siemens Healthineers Sign Strategic Cooperation Agreement at CIIE – Advancing Precision Imaging in Alzheimer’s Disease Diagnosis and Treatment

Sanyou Biopharmaceuticals Completes Series C Financing of Nearly RMB 100 Million – Zero2IPO Industry Investment Fund Backs AI‑Driven Drug Discovery Platform

Sanyou Biopharmaceuticals Completes Series C Financing of Nearly RMB 100 Million – Zero2IPO Industry Investment Fund Backs AI‑Driven Drug Discovery Platform

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDeals

Changchun BCHT Biotechnology to Acquire Full Stake in mRNA R&D Firm Transcend Biomedical

CompanyDeals

Changchun BCHT Biotechnology and IMB CAMS Enter Five-Year Research Pact

CompanyDrug

Changchun BCHT Gains NMPA Approval for Herpes Zoster Vaccine

Show More